Literature DB >> 33472843

Arrestin-Dependent and -Independent Internalization of G Protein-Coupled Receptors: Methods, Mechanisms, and Implications on Cell Signaling.

Ee Von Moo1, Jeffrey R van Senten1, Hans Bräuner-Osborne1, Thor C Møller2.   

Abstract

Agonist-induced endocytosis is a key regulatory mechanism for controlling the responsiveness of the cell by changing the density of cell surface receptors. In addition to the role of endocytosis in signal termination, endocytosed G protein-coupled receptors (GPCRs) have been found to signal from intracellular compartments of the cell. Arrestins are generally believed to be the master regulators of GPCR endocytosis by binding to both phosphorylated receptors and adaptor protein 2 (AP-2) or clathrin, thus recruiting receptors to clathrin-coated pits to facilitate the internalization process. However, many other functions have been described for arrestins that do not relate to their role in terminating signaling. Additionally, there are now more than 30 examples of GPCRs that internalize independently of arrestins. Here we review the methods, pharmacological tools, and cellular backgrounds used to determine the role of arrestins in receptor internalization, highlighting their advantages and caveats. We also summarize key examples of arrestin-independent GPCR endocytosis in the literature and their suggested alternative endocytosis pathway (e.g., the caveolae-dependent and fast endophilin-mediated endocytosis pathways). Finally, we consider the possible function of arrestins recruited to GPCRs that are endocytosed independently of arrestins, including the catalytic arrestin activation paradigm. Technological improvements in recent years have advanced the field further, and, combined with the important implications of endocytosis on drug responses, this makes endocytosis an obvious parameter to include in molecular pharmacological characterization of ligand-GPCR interactions. SIGNIFICANCE STATEMENT: G protein-coupled receptor (GPCR) endocytosis is an important means to terminate receptor signaling, and arrestins play a central role in the widely accepted classical paradigm of GPCR endocytosis. In contrast to the canonical arrestin-mediated internalization, an increasing number of GPCRs are found to be endocytosed via alternate pathways, and the process appears more diverse than the previously defined "one pathway fits all."
Copyright © 2021 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33472843     DOI: 10.1124/molpharm.120.000192

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  6 in total

1.  Functionality of Melatonin Receptors: Internalization.

Authors:  Clémence Dupré; Céline Legros; Jean A Boutin
Journal:  Methods Mol Biol       Date:  2022

2.  Functionality of Melatonin Receptors: Recruitment of β-Arrestin at MT1.

Authors:  Clémence Dupré; Céline Legros; Jean A Boutin
Journal:  Methods Mol Biol       Date:  2022

3.  Apelin Resistance Contributes to Muscle Loss during Cancer Cachexia in Mice.

Authors:  Andrea David Re Cecconi; Mara Barone; Mara Forti; Martina Lunardi; Alfredo Cagnotto; Mario Salmona; Davide Olivari; Lorena Zentilin; Andrea Resovi; Perla Persichitti; Dorina Belotti; Federica Palo; Nobuyuki Takakura; Hiroyasu Kidoya; Rosanna Piccirillo
Journal:  Cancers (Basel)       Date:  2022-04-02       Impact factor: 6.639

Review 4.  Genetically encoded fluorescent biosensors for GPCR research.

Authors:  Hyunbin Kim; In-Yeop Baek; Jihye Seong
Journal:  Front Cell Dev Biol       Date:  2022-09-29

5.  A Cell Membrane-Level Approach to Cicatricial Alopecia Management: Is Caveolin-1 a Viable Therapeutic Target in Frontal Fibrosing Alopecia?

Authors:  Ivan Jozic; Jérémy Chéret; Beatriz Abdo Abujamra; Mariya Miteva; Jennifer Gherardini; Ralf Paus
Journal:  Biomedicines       Date:  2021-05-19

Review 6.  The LPA3 Receptor: Regulation and Activation of Signaling Pathways.

Authors:  Karina Helivier Solís; M Teresa Romero-Ávila; Alejandro Guzmán-Silva; J Adolfo García-Sáinz
Journal:  Int J Mol Sci       Date:  2021-06-23       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.